Search

14 January 2025 - This data file contains statistical data about Australia's COVID-19 vaccinations.

17 June 2025 - Find out how we manage any personal information we collect when you sign up for our MBS Review Advisory Committee communique.

10 July 2025 - Professor Kristine Macartney discusses the importance of the influenza vaccine. The vaccine is free for pregnant women and children aged 6 months to less than five years under the National Immunisation Program.

18 June 2025 - This data file contains statistical data about Australia's COVID-19 vaccinations.

30 September 2024 - The ATAGI 2024 Annual Statement on Immunisation is the fourth publication in this series. The statement highlights the key successes, trends and challenges in the use of vaccines and control of vaccine preventable diseases in Australia in 2023, and includes advice to address key issues for 2024.

24 October 2025 - This weekly report provides a snapshot of data on the impact of COVID-19 in residential aged care facilities nationally in 2025. It includes data on the number of services impacted and number of staff and resident cases, as well as workforce, vaccine rollout, testing and PPE provided to services.

22 May 2025 - This data file contains statistical data about Australia's COVID-19 vaccinations.

16 July 2024 - The ATAGI 2023 Annual Statement on Immunisation is the third publication in this series. It covers key successes, trends and challenges in the use of vaccines and control of vaccine-preventable diseases in 2023. It also signals ATAGI’s priority actions for addressing key issues for 2023.

16 July 2024 - The ATAGI 2022 Annual Statement on Immunisation is the second publication in this series, delayed due to COVID-19. It covers key successes, trends and challenges in the use of vaccines and control of vaccine-preventable diseases in 2021.

7 November 2025 - Cost recovery arrangements commenced on 1 July 2020 for Australian Technical Advisory Group on Immunisation (ATAGI) evaluation that supports Pharmaceutical Benefits Advisory Committee (PBAC) consideration of vaccines for the National Immunisation Program (NIP).